Maria B. Alora-Palli

Author

Also Known As

M. Alora‐Palli, M.B. Alora-Palli, Maria Alora-Palli, Maria Alora‐Palli, Maria B. Alora-Palli, Maria Beatrice Alora-Palli

Publications

440

Citations

H-Index

Concepts

All Affiliations

Massachusetts General Hospital Harvard University Brigham and Women's Hospital

About

Maria B. Alora-Palli is an author at Massachusetts General Hospital specializing in medicine, dermatology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	365
2	Social Sciences	1	1	181
3	Cognitive Science	1	1	181
4	Neuroscience	1	1	181
5	Pathology	1	1	14

Maria B. Alora-Palli

Publications

407

Citations

H-Index

Page 1

	Year	Citations
Prediction of cognition in Parkinson's disease with a clinical–genetic score: a longitudinal analysis of nine cohorts Ganqiang Liu, Joseph J. Locascio, Jean‐Christophe Corvol, The Lancet Neurology Neuroimaging BiomarkersNeurodegenerative DiseasesCognitive ScienceLongitudinal AnalysisNeuropsychological Functioning	2017	181
Cutaneous effects of BRAF inhibitor therapy: a case series Pierre-Olivier Mattei, Maria B. Alora-Palli, Stefan Kraft, Annals of Oncology Clinical DermatologyPharmacotherapyWound HealingDermatologyBraf Inhibitor Therapy	2012	82
Age-induced and photoinduced changes in gene expression profiles in facial skin of Caucasian females across 6 decades of age Alexa B. Kimball, Maria B. Alora-Palli, Makio Tamura, Journal of the American Academy of Dermatology LongevityGeneticsFacial SkinCutaneous BiologyPhotoinduced Changes	2017	67
Comparison of racial distribution of photodermatoses in USA academic dermatology clinics: A multicenter retrospective analysis of 1080 patients over a 10‐year period Remi Hamel, Tasneem F. Mohammad, Adam Chahine, Photodermatology Photoimmunology & Photomedicine	2020	24
Efficacy and Tolerability of a Cosmetically Acceptable Coal Tar Solution in the Treatment of Moderate Plaque Psoriasis Maria B. Alora-Palli, Alexis Perkins, Alicia Van Cott, American Journal of Clinical Dermatology Psoriatic ArthritisClinical DermatologyModerate Plaque PsoriasisSkin PharmacologyDermatology	2010	21
A randomized, double-blind, placebo-controlled, pilot study to assess the efficacy and safety of clindamycin 1.2% and tretinoin 0.025% combination gel for the treatment of acne rosacea over 12 weeks. Anne Lynn S. Chang, Maria B. Alora-Palli, Xinaida Taligare Vasconcelos Lima, PubMed	2012	18
Melanocytic nevi excised during B-Raf proto-oncogene (BRAF) inhibitor therapy: A study of 19 lesions from 10 patients Mark C. Mochel, Marc R. Hammond, Dennie T. Frederick, Journal of the American Academy of Dermatology Tumor BiologyMelanocytic NeviB-raf Proto-oncogeneMedicineMelanoma	2015	14

Page 1